Back to IMRX
UBS Group AG IMRX Position History
Immuneering Corporation • Healthcare
Quarters held
14
Latest value
$81K
Q3 2026
Peak value
$2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $14K |
| Q3 2025 | $821K |
| Q3 2025 | $49K |
| Q4 2025 | $976K |
| Q4 2025 | $266K |
| Q4 2025 | $9K |
| Q1 2026 | $1.8M |
| Q1 2026 | $214K |
| Q1 2026 | $8K |
| Q2 2026 | $2M |
| Q2 2026 | $241K |
| Q3 2026 | $1.1M |
| Q3 2026 | $232K |
| Q3 2026 | $81K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $81K | 19.9K | — | — |
| Q3 2026 | $232K | 56.6K | — | — |
| Q3 2026 | $1.1M | 274.2K | — | — |
| Q2 2026 | $241K | 48.2K | — | — |
| Q2 2026 | $2M | 400.7K | — | — |
| Q1 2026 | $8K | 1.5K | — | — |
| Q1 2026 | $214K | 40.5K | — | — |
| Q1 2026 | $1.8M | 334.3K | — | — |
| Q4 2025 | $9K | 1.4K | — | — |
| Q4 2025 | $266K | 40.5K | — | — |
| Q4 2025 | $976K | 148.4K | — | — |
| Q3 2025 | $49K | 7.1K | — | — |
| Q3 2025 | $821K | 117.4K | — | — |
| Q3 2025 | $14K | 2.0K | — | — |